Efficacy and tolerability of a novel cosmetic growth factor serum when used as part of biweekly diamond tip hydradermabrasion treatments on facial skin

Abstract

AbstractBackgroundGrowth factor preparations have demonstrated effectiveness in reversing age‐related changes in facial skin. TNS® Advanced+ Serum (TNS A+ Serum; SkinMedica®, Allergan Aesthetics, an AbbVie Company) and TNS Advanced+ Pro‐Infusion Serum for DiamondGlow® (DG‐TNS A+; Allergan Aesthetics) combine growth factor technology with active botanical ingredients to target signs of skin aging.AimsThis prospective clinical study evaluated the effectiveness and tolerability of biweekly facial hydradermabrasion (DiamondGlow [DG]; Allergan Aesthetics) plus DG‐TNS A+ combined with at‐home topical TNS A+ Serum.MethodsFemales aged 25–65 years with mild to severe facial photodamage received 6 biweekly DG plus DG‐TNS A+ in‐office treatments with at‐home twice‐daily TNS A+ Serum for 12 weeks. Investigator‐assessed clinical grading of multiple skin attributes, subject self‐assessments, instrumentation measurements, and clinical grading of irritation parameters (0–3, none to severe) were conducted at Visit 1, Day 3, and biweekly from Weeks 2–12.ResultsTwenty‐nine women (Fitzpatrick skin types II–VI; 52% White, 41% African American) were enrolled. Immediate significant improvements after 1 DG plus DG‐TNS A+ treatment were observed for fine lines/wrinkles, skin smoothness (visual and tactile), radiance, and hydration (all p ≤ 0.004). From Weeks 6–12, all investigator‐assessed parameters showed significant improvements versus baseline (all p ≤ 0.002 at Week 12). Mean tolerability scores were <1 across parameters. All subjects (100%) were satisfied with results at Weeks 2–12.ConclusionsThe combination of biweekly hydradermabrasion plus DG‐TNS A+ with at‐home TNS A+ Serum treatments was well tolerated and produced immediate, progressive improvement in multiple signs of photoaging in facial skin.